Gene symbol: Hdac2

Organism: Rattus norvegicus

Summary: Enables several functions, including deacetylase activity; heat shock protein binding activity; and promoter-specific chromatin binding activity. Involved in several processes, including positive regulation of cell differentiation; positive regulation of macromolecule metabolic process; and response to alkaloid. Located in chromatin; cytoplasm; and nucleus. Used to study Peyronie's disease; alcohol use disorder; and anxiety disorder. Biomarker of bronchitis; chronic obstructive pulmonary disease; endometriosis; pulmonary emphysema; and visual epilepsy. Human ortholog(s) of this gene implicated in stomach cancer. Orthologous to human HDAC2 (histone deacetylase 2). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 84577 Ensembl:ENSRNOG00000000604 AllianceGenome:RGD:619976


GO Annotation


Category Term ID Term description
Process GO:0000122 Negative regulation of transcription by RNA polymerase II
Process GO:0000302 Response to reactive oxygen species
Process GO:0001654 Eye development
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001942 Hair follicle development
Process GO:0001975 Response to amphetamine
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003300 Cardiac muscle hypertrophy
Process GO:0006325 Chromatin organization
Process GO:0006338 Chromatin remodeling
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006476 Protein deacetylation
Process GO:0006479 Protein methylation
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006950 Response to stress
Process GO:0006979 Response to oxidative stress
Process GO:0006996 Organelle organization
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007423 Sensory organ development
Process GO:0007507 Heart development
Process GO:0007610 Behavior
Process GO:0007623 Circadian rhythm
Process GO:0008152 Metabolic process
Process GO:0008213 Protein alkylation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008544 Epidermis development
Process GO:0009266 Response to temperature stimulus
Process GO:0009408 Response to heat
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009790 Embryo development
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009913 Epidermal cell differentiation
Process GO:0009966 Regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010469 Regulation of signaling receptor activity
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010558 Negative regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010717 Regulation of epithelial to mesenchymal transition
Process GO:0010718 Positive regulation of epithelial to mesenchymal transition
Process GO:0010720 Positive regulation of cell development
Process GO:0010941 Regulation of cell death
Process GO:0010975 Regulation of neuron projection development
Process GO:0010977 Negative regulation of neuron projection development
Process GO:0014013 Regulation of gliogenesis
Process GO:0014015 Positive regulation of gliogenesis
Process GO:0014070 Response to organic cyclic compound
Process GO:0014074 Response to purine-containing compound
Process GO:0014075 Response to amine
Process GO:0014706 Striated muscle tissue development
Process GO:0014896 Muscle hypertrophy
Process GO:0014897 Striated muscle hypertrophy
Process GO:0016043 Cellular component organization
Process GO:0016358 Dendrite development
Process GO:0016570 Histone modification
Process GO:0016571 Histone methylation
Process GO:0016575 Histone deacetylation
Process GO:0018022 Peptidyl-lysine methylation
Process GO:0018193 Peptidyl-amino acid modification
Process GO:0018205 Peptidyl-lysine modification
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0021537 Telencephalon development
Process GO:0021543 Pallium development
Process GO:0021761 Limbic system development
Process GO:0021766 Hippocampus development
Process GO:0022008 Neurogenesis
Process GO:0022404 Molting cycle process
Process GO:0022405 Hair cycle process
Process GO:0023051 Regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030030 Cell projection organization
Process GO:0030111 Regulation of Wnt signaling pathway
Process GO:0030154 Cell differentiation
Process GO:0030162 Regulation of proteolysis
Process GO:0030178 Negative regulation of Wnt signaling pathway
Process GO:0030182 Neuron differentiation
Process GO:0030326 Embryonic limb morphogenesis
Process GO:0030534 Adult behavior
Process GO:0030855 Epithelial cell differentiation
Process GO:0030900 Forebrain development
Process GO:0031000 Response to caffeine
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031327 Negative regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031344 Regulation of cell projection organization
Process GO:0031345 Negative regulation of cell projection organization
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0032259 Methylation
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032526 Response to retinoic acid
Process GO:0032652 Regulation of interleukin-1 production
Process GO:0032680 Regulation of tumor necrosis factor production
Process GO:0032732 Positive regulation of interleukin-1 production
Process GO:0032760 Positive regulation of tumor necrosis factor production
Process GO:0032922 Circadian regulation of gene expression
Process GO:0032956 Regulation of actin cytoskeleton organization
Process GO:0032970 Regulation of actin filament-based process
Process GO:0033043 Regulation of organelle organization
Process GO:0033554 Cellular response to stress
Process GO:0033993 Response to lipid
Process GO:0034599 Cellular response to oxidative stress
Process GO:0034605 Cellular response to heat
Process GO:0034614 Cellular response to reactive oxygen species
Process GO:0034968 Histone lysine methylation
Process GO:0035051 Cardiocyte differentiation
Process GO:0035094 Response to nicotine
Process GO:0035107 Appendage morphogenesis
Process GO:0035108 Limb morphogenesis
Process GO:0035113 Embryonic appendage morphogenesis
Process GO:0035601 Protein deacylation
Process GO:0035983 Response to trichostatin A
Process GO:0035984 Cellular response to trichostatin A
Process GO:0036211 Protein modification process
Process GO:0036296 Response to increased oxygen levels
Process GO:0040008 Regulation of growth
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042220 Response to cocaine
Process GO:0042221 Response to chemical
Process GO:0042303 Molting cycle
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042475 Odontogenesis of dentin-containing tooth
Process GO:0042476 Odontogenesis
Process GO:0042509 Regulation of tyrosine phosphorylation of STAT protein
Process GO:0042531 Positive regulation of tyrosine phosphorylation of STAT protein
Process GO:0042542 Response to hydrogen peroxide
Process GO:0042633 Hair cycle
Process GO:0042692 Muscle cell differentiation
Process GO:0042733 Embryonic digit morphogenesis
Process GO:0042981 Regulation of apoptotic process
Process GO:0043010 Camera-type eye development
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043279 Response to alkaloid
Process GO:0043392 Negative regulation of DNA binding
Process GO:0043412 Macromolecule modification
Process GO:0043414 Macromolecule methylation
Process GO:0043433 Negative regulation of DNA-binding transcription factor activity
Process GO:0043586 Tongue development
Process GO:0043587 Tongue morphogenesis
Process GO:0043588 Skin development
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044260 Cellular macromolecule metabolic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045471 Response to ethanol
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045685 Regulation of glial cell differentiation
Process GO:0045687 Positive regulation of glial cell differentiation
Process GO:0045862 Positive regulation of proteolysis
Process GO:0045892 Negative regulation of transcription, DNA-templated
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045926 Negative regulation of growth
Process GO:0045934 Negative regulation of nucleobase-containing compound metabolic process
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046620 Regulation of organ growth
Process GO:0046621 Negative regulation of organ growth
Process GO:0046677 Response to antibiotic
Process GO:0048149 Behavioral response to ethanol
Process GO:0048468 Cell development
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048520 Positive regulation of behavior
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048598 Embryonic morphogenesis
Process GO:0048638 Regulation of developmental growth
Process GO:0048640 Negative regulation of developmental growth
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048666 Neuron development
Process GO:0048699 Generation of neurons
Process GO:0048713 Regulation of oligodendrocyte differentiation
Process GO:0048714 Positive regulation of oligodendrocyte differentiation
Process GO:0048731 System development
Process GO:0048736 Appendage development
Process GO:0048738 Cardiac muscle tissue development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048880 Sensory system development
Process GO:0050730 Regulation of peptidyl-tyrosine phosphorylation
Process GO:0050731 Positive regulation of peptidyl-tyrosine phosphorylation
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050795 Regulation of behavior
Process GO:0050896 Response to stimulus
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051100 Negative regulation of binding
Process GO:0051101 Regulation of DNA binding
Process GO:0051128 Regulation of cellular component organization
Process GO:0051129 Negative regulation of cellular component organization
Process GO:0051146 Striated muscle cell differentiation
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051253 Negative regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051276 Chromosome organization
Process GO:0051493 Regulation of cytoskeleton organization
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051896 Regulation of protein kinase B signaling
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0055001 Muscle cell development
Process GO:0055006 Cardiac cell development
Process GO:0055007 Cardiac muscle cell differentiation
Process GO:0055013 Cardiac muscle cell development
Process GO:0055021 Regulation of cardiac muscle tissue growth
Process GO:0055022 Negative regulation of cardiac muscle tissue growth
Process GO:0055093 Response to hyperoxia
Process GO:0060043 Regulation of cardiac muscle cell proliferation
Process GO:0060044 Negative regulation of cardiac muscle cell proliferation
Process GO:0060173 Limb development
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060297 Regulation of sarcomere organization
Process GO:0060322 Head development
Process GO:0060420 Regulation of heart growth
Process GO:0060429 Epithelium development
Process GO:0060537 Muscle tissue development
Process GO:0060548 Negative regulation of cell death
Process GO:0060788 Ectodermal placode formation
Process GO:0060789 Hair follicle placode formation
Process GO:0060828 Regulation of canonical Wnt signaling pathway
Process GO:0060998 Regulation of dendritic spine development
Process GO:0061000 Negative regulation of dendritic spine development
Process GO:0061029 Eyelid development in camera-type eye
Process GO:0061061 Muscle structure development
Process GO:0061117 Negative regulation of heart growth
Process GO:0061196 Fungiform papilla development
Process GO:0061197 Fungiform papilla morphogenesis
Process GO:0061198 Fungiform papilla formation
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065009 Regulation of molecular function
Process GO:0070301 Cellular response to hydrogen peroxide
Process GO:0070482 Response to oxygen levels
Process GO:0070734 Histone H3-K27 methylation
Process GO:0070828 Heterochromatin organization
Process GO:0070848 Response to growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0070932 Histone H3 deacetylation
Process GO:0070933 Histone H4 deacetylation
Process GO:0071236 Cellular response to antibiotic
Process GO:0071300 Cellular response to retinoic acid
Process GO:0071310 Cellular response to organic substance
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071559 Response to transforming growth factor beta
Process GO:0071560 Cellular response to transforming growth factor beta stimulus
Process GO:0071696 Ectodermal placode development
Process GO:0071697 Ectodermal placode morphogenesis
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0071867 Response to monoamine
Process GO:0071868 Cellular response to monoamine stimulus
Process GO:0071869 Response to catecholamine
Process GO:0071870 Cellular response to catecholamine stimulus
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090090 Negative regulation of canonical Wnt signaling pathway
Process GO:0090311 Regulation of protein deacetylation
Process GO:0090596 Sensory organ morphogenesis
Process GO:0097305 Response to alcohol
Process GO:0098732 Macromolecule deacylation
Process GO:0098773 Skin epidermis development
Process GO:0110020 Regulation of actomyosin structure organization
Process GO:0120035 Regulation of plasma membrane bounded cell projection organization
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0150063 Visual system development
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1901983 Regulation of protein acetylation
Process GO:1901984 Negative regulation of protein acetylation
Process GO:1902435 Regulation of male mating behavior
Process GO:1902437 Positive regulation of male mating behavior
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902679 Negative regulation of RNA biosynthetic process
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1902893 Regulation of miRNA transcription
Process GO:1902894 Negative regulation of miRNA transcription
Process GO:1902903 Regulation of supramolecular fiber organization
Process GO:1903350 Response to dopamine
Process GO:1903351 Cellular response to dopamine
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903507 Negative regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903555 Regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903557 Positive regulation of tumor necrosis factor superfamily cytokine production
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000241 Regulation of reproductive process
Process GO:2000243 Positive regulation of reproductive process
Process GO:2000273 Positive regulation of signaling receptor activity
Process GO:2000628 Regulation of miRNA metabolic process
Process GO:2000629 Negative regulation of miRNA metabolic process
Process GO:2000756 Regulation of peptidyl-lysine acetylation
Process GO:2000757 Negative regulation of peptidyl-lysine acetylation
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001233 Regulation of apoptotic signaling pathway
Process GO:2001234 Negative regulation of apoptotic signaling pathway
Process GO:2001242 Regulation of intrinsic apoptotic signaling pathway
Process GO:2001243 Negative regulation of intrinsic apoptotic signaling pathway
Component GO:0000118 Histone deacetylase complex
Component GO:0000228 Nuclear chromosome
Component GO:0000781 Chromosome, telomeric region
Component GO:0000785 Chromatin
Component GO:0000792 Heterochromatin
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005654 Nucleoplasm
Component GO:0005657 Replication fork
Component GO:0005667 Transcription regulator complex
Component GO:0005694 Chromosome
Component GO:0005737 Cytoplasm
Component GO:0016580 Sin3 complex
Component GO:0016581 NuRD complex
Component GO:0017053 Transcription repressor complex
Component GO:0031519 PcG protein complex
Component GO:0031974 Membrane-enclosed lumen
Component GO:0031981 Nuclear lumen
Component GO:0032991 Protein-containing complex
Component GO:0034708 Methyltransferase complex
Component GO:0035097 Histone methyltransferase complex
Component GO:0035098 ESC/E(Z) complex
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0043233 Organelle lumen
Component GO:0070013 Intracellular organelle lumen
Component GO:0070603 SWI/SNF superfamily-type complex
Component GO:0070822 Sin3-type complex
Component GO:0090545 CHD-type complex
Component GO:0090571 RNA polymerase II transcription repressor complex
Component GO:0098687 Chromosomal region
Component GO:0110165 Cellular anatomical entity
Component GO:0140513 Nuclear protein-containing complex
Component GO:1902494 Catalytic complex
Component GO:1904949 ATPase complex
Component GO:1990234 Transferase complex
Function GO:0000976 Transcription cis-regulatory region binding
Function GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding
Function GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
Function GO:0000987 Cis-regulatory region sequence-specific DNA binding
Function GO:0001067 Transcription regulatory region nucleic acid binding
Function GO:0001221 Transcription coregulator binding
Function GO:0001222 Transcription corepressor binding
Function GO:0003676 Nucleic acid binding
Function GO:0003677 DNA binding
Function GO:0003682 Chromatin binding
Function GO:0003690 Double-stranded DNA binding
Function GO:0003824 Catalytic activity
Function GO:0004407 Histone deacetylase activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008134 Transcription factor binding
Function GO:0016787 Hydrolase activity
Function GO:0016810 Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds
Function GO:0016811 Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides
Function GO:0019213 Deacetylase activity
Function GO:0019899 Enzyme binding
Function GO:0019904 Protein domain specific binding
Function GO:0031072 Heat shock protein binding
Function GO:0031490 Chromatin DNA binding
Function GO:0033558 Protein lysine deacetylase activity
Function GO:0034739 Histone deacetylase activity (H4-K16 specific)
Function GO:0035851 Krueppel-associated box domain binding
Function GO:0042826 Histone deacetylase binding
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0043565 Sequence-specific DNA binding
Function GO:0046872 Metal ion binding
Function GO:0051059 NF-kappaB binding
Function GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:0140297 DNA-binding transcription factor binding
Function GO:0160008 Protein decrotonylase activity
Function GO:0160009 Histone decrotonylase activity
Function GO:0160010 Protein de-2-hydroxyisobutyrylase activity
Function GO:1901363 Heterocyclic compound binding
Function GO:1990837 Sequence-specific double-stranded DNA binding
Function GO:1990841 Promoter-specific chromatin binding

Pathway annotation


Category Term ID Term description
RCTM RNO-109582 Hemostasis
RCTM RNO-1257604 PIP3 activates AKT signaling
RCTM RNO-162582 Signal Transduction
RCTM RNO-201556 Signaling by ALK
RCTM RNO-212436 Generic Transcription Pathway
RCTM RNO-2990846 SUMOylation
RCTM RNO-3108232 SUMO E3 ligases SUMOylate target proteins
RCTM RNO-3214815 HDACs deacetylate histones
RCTM RNO-3247509 Chromatin modifying enzymes
RCTM RNO-350054 Notch-HLH transcription pathway
RCTM RNO-3700989 Transcriptional Regulation by TP53
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-4551638 SUMOylation of chromatin organization proteins
RCTM RNO-4839726 Chromatin organization
RCTM RNO-5633007 Regulation of TP53 Activity
RCTM RNO-597592 Post-translational protein modification
RCTM RNO-6804758 Regulation of TP53 Activity through Acetylation
RCTM RNO-6807070 PTEN Regulation
RCTM RNO-73762 RNA Polymerase I Transcription Initiation
RCTM RNO-73854 RNA Polymerase I Promoter Clearance
RCTM RNO-73857 RNA Polymerase II Transcription
RCTM RNO-73864 RNA Polymerase I Transcription
RCTM RNO-74160 Gene expression (Transcription)
RCTM RNO-8943724 Regulation of PTEN gene transcription
RCTM RNO-8986944 Transcriptional Regulation by MECP2
RCTM RNO-9006925 Intracellular signaling by second messengers
RCTM RNO-9006934 Signaling by Receptor Tyrosine Kinases
RCTM RNO-9022692 Regulation of MECP2 expression and activity
RCTM RNO-9701898 STAT3 nuclear events downstream of ALK signaling
RCTM RNO-983231 Factors involved in megakaryocyte development and platelet production
WikiPathways WP1279 Estrogen signaling
WikiPathways WP457 TNF-alpha NF-kB signaling pathway
KEGG rno03082 ATP-dependent chromatin remodeling
KEGG rno03083 Polycomb repressive complex
KEGG rno04110 Cell cycle
KEGG rno04213 Longevity regulating pathway - multiple species
KEGG rno04330 Notch signaling pathway
KEGG rno04350 TGF-beta signaling pathway
KEGG rno04613 Neutrophil extracellular trap formation
KEGG rno04919 Thyroid hormone signaling pathway
KEGG rno05016 Huntington disease
KEGG rno05031 Amphetamine addiction
KEGG rno05034 Alcoholism
KEGG rno05165 Human papillomavirus infection
KEGG rno05169 Epstein-Barr virus infection
KEGG rno05200 Pathways in cancer
KEGG rno05202 Transcriptional misregulation in cancer
KEGG rno05203 Viral carcinogenesis
KEGG rno05206 MicroRNAs in cancer
KEGG rno05220 Chronic myeloid leukemia

Expression profile of Hdac2 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 4.1949625
GSM2685202 MX2 tissue: Myocardium gender: female 3.8818872
GSM2685203 MX3 tissue: Myocardium gender: female 4.430077
GSM2685204 MX4 tissue: Myocardium gender: male 4.7685165
GSM2685205 DZ1 tissue: Myocardium gender: male 3.5710707
GSM2685206 DZ2 tissue: Myocardium gender: male 2.7902672
GSM2685207 DZ3 tissue: Myocardium gender: female 4.2039413
GSM2685208 DZ4 tissue: Myocardium gender: female 4.1388154
GSM2685209 JJ1 tissue: Myocardium gender: male 4.4813633
GSM2685210 JJ2 tissue: Myocardium gender: female 4.0276637
GSM2685211 JJ3 tissue: Myocardium gender: female 3.750511
GSM2685212 JJ4 tissue: Myocardium gender: male 4.3094463
GSM2685213 NG1 tissue: Myocardium gender: male 4.1058884
GSM2685214 NG2 tissue: Myocardium gender: female 3.8818872
GSM2685215 NG3 tissue: Myocardium gender: male 4.144447
GSM2685216 NG4 tissue: Myocardium gender: female 4.3796997
GSM2685217 YL1 tissue: Myocardium gender: male 3.3637476
GSM2685218 YL2 tissue: Myocardium gender: male 2.740888
GSM2685219 YL3 tissue: Myocardium gender: female 3.7246912
GSM2685220 YL4 tissue: Myocardium gender: female 4.0454164
GSM2685221 QC1 tissue: Myocardium gender: male 3.79889
GSM2685222 QC2 tissue: Myocardium gender: male 3.5778165
GSM2685223 QC3 tissue: Myocardium gender: female 3.9573753
GSM2685224 QC4 tissue: Myocardium gender: female 3.5847838

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 777.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 607.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 701.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 654.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 836.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 717.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 767.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1752.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 645.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 792.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 718.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1300.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 640.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 688.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 817.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 924.0

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 41.296
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 46.177
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 39.432
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 45.015
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 42.184

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 11.67719745
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 11.785004
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 11.8803237

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 404.9
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 267.4
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 398.5
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 417.1
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 393.3
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 244.6
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 203.6
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 209.9
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 178.3
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 214.1
GSM27494 CTL_a (control, 1st replicate) 366.1
GSM27495 CTL_b (control, 2nd replicate) 499.5
GSM27496 CTL_c (control, 3rd replicate) 356.0
GSM27497 CTL_d (control, 4th replicate) 346.2
GSM27498 CTL_e (control, 5th replicate) 261.9
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 352.4
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 511.8
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 342.3
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 323.9
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 343.0
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 164.1
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 188.9
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 274.2
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 262.3
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 256.3
GSM27509 ISCH_a (ischemia, 1st replicate) 225.1
GSM27510 ISCH_b (ischemia, 2nd replicate) 275.5
GSM27511 ISCH_c (ischemia, 3rd replicate) 305.5
GSM27512 ISCH_d (ischemia, 4th replicate) 449.9
GSM27513 ISCH_e (ischemia, 5th replicate) 283.0

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 1071.2
GSM30791 baseline control 02 male, 275-300g 1045.3
GSM30792 baseline control 03 male, 275-300g 1102.5
GSM30793 baseline control 04 male, 275-300g 1137.4
GSM30794 baseline control 05 male, 275-300g 1087.8
GSM30795 baseline control 06 male, 275-300g 1076.1
GSM30796 baseline control 07 male, 275-300g 1076.6
GSM30797 baseline control 08 male, 275-300g 853.0
GSM30798 baseline control 09 male, 275-300g 779.3
GSM30799 pain 01 1012.8
GSM30800 pain 02 1053.9
GSM30801 pain 03 1095.2
GSM30802 pain 04 1002.7
GSM30803 pain 05 1095.7
GSM30804 FC 01 864.7
GSM30805 FC 02 978.8
GSM30806 FC 03 1193.3
GSM30807 FC 04 933.2
GSM30808 FC 05 1131.7
GSM30809 IFC 01 1023.7
GSM30810 IFC 02 984.4
GSM30811 IFC 03 1008.0
GSM30812 IFC 04 1188.7
GSM30813 IFC 05 1092.6
GSM99800 isoflurane 01 male, 275-300g 1118.7
GSM99801 isoflurane 02 male, 275-300g 1024.5
GSM99802 isoflurane 03 male, 275-300g 1128.7
GSM99803 isoflurane 04 male, 275-300g 1294.4
GSM99804 isoflurane 05 male, 275-300g 952.3

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 362.6159
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 312.988
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 281.5695
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 328.1661
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 275.9492
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 270.4425
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 326.7704
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 324.3158
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 358.0011

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 10.0712
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 10.0832
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 10.6037
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 10.8108
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 10.0167
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 9.8241
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 9.68818
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 10.0328
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 10.1575
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 10.3945
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 10.5847
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 10.1306
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 10.1009
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 10.4381
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 9.88648
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 10.0172

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 10.25179
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 9.853442
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 10.048098
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 10.01454
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 9.859654
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 9.95061
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.107907
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 9.84522
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.08092
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.027163
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.07758
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 9.946967
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.097078
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 9.659355
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.087908
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.123767
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.404412
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 9.932113
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.128068
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.10473
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.655398
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.071579
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.587301
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.356909
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.298311
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 9.806815
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 9.839327
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 9.723708
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 9.842562
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 9.993921
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.042819
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.015626
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 9.897563
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.084704
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.058488
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.076082
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.08207
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.111621
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.585332
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.273106
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 9.43318
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 9.358904
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 9.715574
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 9.542677
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 9.728931

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1202.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1167.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1031.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 970.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1038.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 739.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1103.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 973.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 766.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1532.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 973.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1135.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1003.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1437.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1285.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 713.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1139.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1084.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 791.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 750.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1013.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1521.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1319.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1209.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1070.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 607.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1091.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1122.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1311.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1392.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1152.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1426.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1225.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1005.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1302.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 698.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 29.845081
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 21.544098
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 28.092817
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 21.678005

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.0368
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.113
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.0403
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 -0.865
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.000509
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0206
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.0749
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.157
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0872
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.0469
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0403
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.0441

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 79.7
GSM5121 Isoflurane single exposure control-2 97.8
GSM5122 Isoflurane single exposure control-3 111.9
GSM5124 Isoflurane single exposure 1 hr-1 99.0
GSM5126 Isoflurane single exposure 1 hr-2 92.7
GSM5127 Isoflurane single exposure 2 hr-1 88.2
GSM5130 Isoflurane single exposure 2 hr-2 68.9
GSM5131 Isoflurane single exposure 2 hr-3 84.3

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.42111242
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.360750901
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 9.618887461
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 9.604909685
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 9.624709781
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 9.236889443
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.39236702
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 9.456531201
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.583350055
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.653084056
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.771483178
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.928252392
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.098665096
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.94118481
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.645617288
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.380057876
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.063749239
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.962636015
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.151889348
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.302034535
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.945736227
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 9.335932138
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.427248224
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.401941427

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.46205
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.829874
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.344083
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 8.657864
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 8.734016
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.50831
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.759953
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.254171
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.594856
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 8.5896
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.762973
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.447073
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 8.565894
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.722468
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.91129
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.49467
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 8.905767
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.5981
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.969846
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.295405
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 8.785501
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.559561
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.804477
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.475728

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 1280.212
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 1350.075

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 3196.690505
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 2619.972434
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 2378.214433
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2778.134688
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2952.69153
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 2777.598862
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 3053.400905
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 2828.553227
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 3036.681346
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2459.201845
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2245.932734
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2558.223039
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1905.125018
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2840.383965

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.42111242
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.360750901
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 9.618887461
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 9.604909685
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 9.624709781
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 9.236889443
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.39236702
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 9.456531201
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.583350055
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.653084056
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.771483178
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.928252392
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.098665096
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 8.94118481
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.645617288
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.380057876
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.063749239
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.962636015
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.151889348
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.302034535
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.945736227
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 9.335932138
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.427248224
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.401941427
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 3196.690505
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 2619.972434
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 2378.214433
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2778.134688
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2952.69153
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 2777.598862
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 3053.400905
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 2828.553227
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 3036.681346
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2459.201845
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 2245.932734
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2558.223039
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1905.125018
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2840.383965

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 167.6
GSM5084 Control 2 133.5
GSM5085 Control 3 107.8
GSM5086 Control 4 142.0
GSM5087 Control 5 128.2
GSM5090 Control 6 139.6
GSM5105 Control 7 130.8
GSM5106 Control 8 114.1
GSM5107 Control 9 119.6
GSM5108 Halothane 10 exposure-1 145.3
GSM5109 Halothane 10 exposures-2 150.6
GSM5110 Halothane 10 exposures-3 138.6
GSM5111 Halothane 5 exposures-1 137.1
GSM5112 Halothane 5 exposures-2 108.1
GSM5113 Halothane 5 exposures-3 97.2
GSM5114 Isoflurane 10 exposures-1 159.5
GSM5115 Isoflurane 10 exposures-2 152.4
GSM5116 Isoflurane 10 exposures-3 118.8
GSM5117 Isoflurane 5 exposures-1 123.2
GSM5118 Isoflurane 5 exposures-2 146.5
GSM5119 Isoflurane 5 exposures-3 131.1
GSM11379 Control 10 117.3
GSM11380 Control 11 109.2
GSM11381 Control 12 106.1

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 543.309
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 545.423